1684 / 1835
IELSG 32
•
Rituximab improves outcomes for patients with
systemic DLBCL but no randomised study has reported
its impact on outcome of PCNSL
•
Consolidation with WBRT improves survival but is
associated with neurotoxicity and cognitive decline
•
Single arm phase II data shows good outcomes with
HDT and autologous PBSCT
•
Could HDT+PBSCT replace WBRT?